John Flanagan's Contact Details

John Flanagan's Company Details

Juvent Medical Inc

Somerset, NJ, US • 20 - 49 Employees
Medical Equipment

Juvent delivers clinically validated solutions to improve users' musculoskeletal health. Our patented Micro-Impact Platform® has clinically demonstrated the ability to help users manage their osteoporosis and improve bone health, non-invasively. Additionally, our technology helps users decrease joint pain, improve balance, and increase lymphatic drainage. Juvent's Micro-Impact is proving to be an essential ingredient for total health and vitality; a Vitamin of ExerciseˇA recent Clinical Trial conducted by St. Jude Hospital for Children, published in JAMA Oncology, showed an 11% improvement in BMD in the active group using Juvent's Micro-Impact Platform. (see the study for details)Additionally, Juvent has developed a novel bone health supplement, HydroxyBMD. HydroxyBMD offers users a unique microcrystalline hydroxyapatite (calcium/mineral) complex paired with other proprietary ingredients that promote healthy bone. As an AM/PM formula, the AM supplement is calcium-free, giving users and physicians treatment flexibility.For more details see - www.hydroxybmd.com Juvent Health www.juventhealth.com